share_log

Credit Suisse Downgrades Aveanna Healthcare Hldgs to Underperform, Lowers Price Target to $1

Credit Suisse Downgrades Aveanna Healthcare Hldgs to Underperform, Lowers Price Target to $1

瑞信將 Aveanna 醫療保健控股的評級降至表現大市,將目標價格降至 1 美元
Benzinga Real-time News ·  2023/01/27 07:15

Credit Suisse analyst A.J. Rice downgrades Aveanna Healthcare Hldgs (NASDAQ:AVAH) from Neutral to Underperform and lowers the price target from $2 to $1.

瑞士信貸分析師A.J.賴斯將Aveanna Healthcare Hldgs(納斯達克:AVA)的評級從中性下調至表現不佳,並將目標價從2美元下調至1美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論